Eleonore Beurel

Dr. Eleonore Beurel


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2022 in Neurobiology of Disease
Verified
Journal Article
Open access
EMEva M. Medina-Rodriguez
Eva M. Medina-Rodriguez
EBEleonore Beurel
Eleonore Beurel
The blood brain barrier (BBB) is a vital structure to protect the brain, tightly filtering the passage of nutrients and molecules from the blood to the brain. This is critical for maintaining the proper functioning of the brain, and any disruption in the BBB has detrimental consequences often leading to diseases. It is not clear whether disruption of the BBB occurs first in depression or is the consequence of the disease, however disruption of the BBB has been observed in depressed patients and evidence points to the role of important culprits in depression, stress and inflammation in disrupting the integrity of the BBB. The mechanisms whereby stress, and inflammation affect the BBB remain to be fully understood. Yet, the role of cytokines in regulating tight junction protein expression seems crucial. Altogether, the findings in depression suggest that acting at the BBB level might provide therapeutic benefit in depression.

17 August 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
EMEva M. Medina-Rodriguez
Eva M. Medina-Rodriguez
JLJeffrey Lowell
Jeffrey Lowell
RWRyan J. Worthen
Ryan J. Worthen
SSShariful A. Syed
Shariful A. Syed
EBEleonore Beurel
Eleonore Beurel
Major depressive disorder (MDD) is a prevalent and debilitating disorder, often fatal. Treatment options are few and often do not provide immediate relief to the patients. The increasing involvement of inflammation in the pathology of MDD has provided new potential therapeutic avenues. Cytokine levels are elevated in the blood and cerebrospinal fluid of MDD patients whereas immune cells often exhibit an immunosuppressed phenotype in MDD patients. Blocking cytokine actions in patients exhibiting MDD show some antidepressant efficacy. However, the role of cytokines, and the immune response in MDD patients remain to be determined. We reviewed here the roles of the innate and adaptive immune systems in MDD, as well as potential mechanisms whereby the immune response might be regulated in MDD.

22 August 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RWRyan J. Worthen
Ryan J. Worthen
SZSusan S. Garzon Zighelboim
Susan S. Garzon Zighelboim
CJCamila S. Torres Jaramillo
Camila S. Torres Jaramillo
EBEleonore Beurel
Eleonore Beurel
Background: Major depressive disorder is a widespread mood disorder. One of the most debilitating symptoms patients often experience is cognitive impairment. Recent findings suggest that inflammation is associated with depression and impaired cognition. Pro-inflammatory cytokines are elevated in the blood of depressed patients and impair learning and memory processes, suggesting that an anti-inflammatory approach might be beneficial for both depression and cognition.Methods: We subjected mice to the learned helplessness paradigm and evaluated novel object recognition and spatial memory. Mice were treated with IL-10 intranasally or/and microglia cells were depleted using PLX5622. Statistical differences were tested using ANOVA orttests.Results: We first established a mouse model of depression in which learning and memory are impaired. We found that learned helplessness (LH) impairs novel object recognition (NOR) and spatial working memory. LH mice also exhibit reduced hippocampal dendritic spine density and increased microglial activation compared to non-shocked (NS) mice or mice that were subjected to the learned helpless paradigm but did not exhibit learned helplessness (non-learned helpless or NLH). These effects are mediated by microglia, as treatment with PLX5622, which depletes microglia, restores learning and memory and hippocampal dendritic spine density in LH mice. However, PLX5622 also impairs learning and memory and reduces hippocampal dendritic spine density in NLH mice, suggesting that microglia in NLH mice produce molecules that promote learning and memory. We found that microglial interleukin (IL)-10 levels are reduced in LH mice, and IL-10 administration is sufficient to restore NOR, spatial working memory, and hippocampal dendritic spine density in LH mice, and in NLH mice treated with PLX5622 consistent with a pro-cognitive role for IL-10.Conclusions: Altogether these data demonstrate the critical role of IL-10 in promoting learning and memory after learned helplessness.

1 October 2020 in American Journal of Psychiatry
Verified
Journal Article
Closed access
EMEva M. Medina-Rodriguez
Eva M. Medina-Rodriguez
DMDerik Madorma
Derik Madorma
GOGregory O’connor
Gregory O’connor
BMBrittany L. Mason
Brittany L. Mason
DHDongmei Han
Dongmei Han
EBEleonore Beurel
Eleonore Beurel

1 October 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
EBEleonore Beurel
Eleonore Beurel
JLJeffrey Lowell
Jeffrey Lowell
RJRichard S. Jope
Richard S. Jope

29 January 2022 in Neurobiology of Disease
Verified
Journal Article
Open access
RWRyan J. Worthen
Ryan J. Worthen
EBEleonore Beurel
Eleonore Beurel
Postpartum depression (PPD) is the most common psychiatric complication associated with pregnancy and childbirth with debilitating symptoms that negatively impact the quality of life of the mother as well as inflict potentially long-lasting developmental impairments to the child. Much of the theoretical pathophysiology put forth to explain the emergence of PPD overlaps with that of major depressive disorder (MDD) and, although not conventionally described in such terms, can be seen as neurodegenerative in nature. Framing the disorder from the perspective of the well-established inflammatory theory of depression, symptoms are thought to be driven by dysregulation, and subsequent hyperactivation of the body’s immune response to stress. Compounded by physiological stressors such as drastic fluctuations in hormone signaling, physical and psychosocial stressors placed upon new mothers lay bare a number of significant vulnerabilities, or points of potential failure, in systems critical for maintaining healthy brain function. The inability to compensate or properly adapt to meet the changing demands placed upon these systems has the potential to damage neurons, hinder neuronal growth and repair, and disrupt neuronal circuit integrity such that essential functional outputs like mood and cognition are altered. The impact of this deterioration in brain function, which includes depressive symptoms, extends to the child who relies on the mother for critical life-sustaining care as well as important cognitive stimulation, accentuating the need for further research.